The mental health of staff working on intensive care units over the COVID-19 winter surge of 2020 in England: a cross sectional survey.


Journal

British journal of anaesthesia
ISSN: 1471-6771
Titre abrégé: Br J Anaesth
Pays: England
ID NLM: 0372541

Informations de publication

Date de publication:
06 2022
Historique:
received: 21 12 2021
revised: 09 03 2022
accepted: 10 03 2022
pubmed: 26 4 2022
medline: 20 5 2022
entrez: 25 4 2022
Statut: ppublish

Résumé

The COVID-19 pandemic generated a surge of critically ill patients greater than the capacity of the UK National Health Service (NHS). There have been multiple well-documented impacts associated with the national COVID-19 pandemic surge on ICU staff, including an increased prevalence of mental health disorders on a scale potentially sufficient to impair high-quality care delivery. We investigated the prevalence of five mental health outcomes; explored demographic and professional predictors of poor mental health outcomes; and describe the prevalence of functional impairment; and explore demographic and professional predictors of functional impairment in ICU staff over the 2020/2021 winter COVID-19 surge in England. English ICU staff were surveyed before, during, and after the winter 2020/2021 surge using a survey which comprised validated measures of mental health. A total of 6080 surveys were completed, by ICU nurses (57.5%), doctors (27.9%), and other healthcare staff (14.5%). Reporting probable mental health disorders increased from 51% (before) to 64% (during), and then decreased to 46% (after). Younger, less experienced nursing staff were most likely to report probable mental health disorders. During and after the winter, >50% of participants met threshold criteria for functional impairment. Staff who reported probable post-traumatic stress disorder, anxiety, or depression were more likely to meet threshold criteria for functional impairment. The winter of 2020/2021 was associated with an increase in poor mental health outcomes and functional impairment amongst ICU staff during a period of peak caseload. These effects are likely to impact on patient care outcomes and the longer-term resilience of the healthcare workforce.

Sections du résumé

BACKGROUND
The COVID-19 pandemic generated a surge of critically ill patients greater than the capacity of the UK National Health Service (NHS). There have been multiple well-documented impacts associated with the national COVID-19 pandemic surge on ICU staff, including an increased prevalence of mental health disorders on a scale potentially sufficient to impair high-quality care delivery. We investigated the prevalence of five mental health outcomes; explored demographic and professional predictors of poor mental health outcomes; and describe the prevalence of functional impairment; and explore demographic and professional predictors of functional impairment in ICU staff over the 2020/2021 winter COVID-19 surge in England.
METHODS
English ICU staff were surveyed before, during, and after the winter 2020/2021 surge using a survey which comprised validated measures of mental health.
RESULTS
A total of 6080 surveys were completed, by ICU nurses (57.5%), doctors (27.9%), and other healthcare staff (14.5%). Reporting probable mental health disorders increased from 51% (before) to 64% (during), and then decreased to 46% (after). Younger, less experienced nursing staff were most likely to report probable mental health disorders. During and after the winter, >50% of participants met threshold criteria for functional impairment. Staff who reported probable post-traumatic stress disorder, anxiety, or depression were more likely to meet threshold criteria for functional impairment.
CONCLUSIONS
The winter of 2020/2021 was associated with an increase in poor mental health outcomes and functional impairment amongst ICU staff during a period of peak caseload. These effects are likely to impact on patient care outcomes and the longer-term resilience of the healthcare workforce.

Identifiants

pubmed: 35465953
pii: S0007-0912(22)00140-4
doi: 10.1016/j.bja.2022.03.016
pmc: PMC8942706
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

971-979

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declarations of interest NG runs a consultancy which provides the NHS with active listening and peer support training. KF works at University College London Hospitals as a consultant anaesthetist, holds an academic chair at University College London, and is seconded to NHS England as an advisor. HWWP has received funding from Public Health England and from NHS England. HWWP has a PhD student who works at and has fees paid by AstraZeneca. KK works for the Care Quality Commission.

Références

Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Br J Psychiatry. 2002 May;180:461-4
pubmed: 11983645
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Intensive Care Med. 2015 Feb;41(2):273-84
pubmed: 25576157
Int J Occup Environ Health. 2009 Jul-Sep;15(3):291-8
pubmed: 19650584
BMJ Open. 2022 Jan 11;12(1):e047748
pubmed: 35017230
J Psychiatr Res. 2022 Sep;153:254-259
pubmed: 35843066
Front Psychiatry. 2021 Jan 27;12:602614
pubmed: 33584383
BMJ. 2020 Mar 26;368:m1211
pubmed: 32217624
Occup Med (Lond). 2021 Apr 9;71(2):62-67
pubmed: 33434920
BJPsych Open. 2020 Dec 29;7(1):e24
pubmed: 33371927
Ann Epidemiol. 2010 Dec;20(12):931-8
pubmed: 21074108
Br J Psychiatry. 2018 Dec;213(6):690-697
pubmed: 30295216
Psychiatry Res. 2021 Jun;300:113920
pubmed: 33882397
J Gen Intern Med. 2017 Apr;32(4):475-482
pubmed: 27785668
Acad Psychiatry. 2021 Oct;45(5):557-565
pubmed: 34128193
Int J Environ Res Public Health. 2020 Dec 15;17(24):
pubmed: 33333893
Indian J Psychol Med. 2020 Jul 06;42(4):353-358
pubmed: 33398224
BMJ Open. 2020 Aug 11;10(8):e039851
pubmed: 32788191
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Apr 20;107:110247
pubmed: 33476692
Ann Intern Med. 2019 Oct 15;171(8):555-567
pubmed: 31590181
Transl Psychiatry. 2021 Mar 15;11(1):169
pubmed: 33723233
BMC Public Health. 2012 Sep 17;12:797
pubmed: 22985427
Behav Res Ther. 2005 May;43(5):585-94
pubmed: 15865914
BMC Public Health. 2021 Jan 9;21(1):104
pubmed: 33422039
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941

Auteurs

Charlotte E Hall (CE)

Behavioural Science and Insights Unit, UK Health Security Agency, Salisbury, UK.

Joanna Milward (J)

Behavioural Science and Insights Unit, UK Health Security Agency, Salisbury, UK. Electronic address: neil.greenberg@kcl.ac.uk.

Cristina Spoiala (C)

Behavioural Science and Insights Unit, UK Health Security Agency, Salisbury, UK.

Jaskiran K Bhogal (JK)

Behavioural Science and Insights Unit, UK Health Security Agency, Salisbury, UK.

Dale Weston (D)

Behavioural Science and Insights Unit, UK Health Security Agency, Salisbury, UK.

Henry W W Potts (HWW)

Institute of Health Informatics and, London, UK.

Tristan Caulfield (T)

Department of Computer Science, University College London, London, UK.

Michael Toolan (M)

King's College Hospital, London, UK; National Institute for Health and Care Excellence, London, UK.

Kate Kanga (K)

Department of Anaesthesia, Guy's & St Thomas' NHS Trust, London, UK.

Sarah El-Sheikha (S)

Department of Anaesthesia, Mersey Deanery, Liverpool, UK.

Kevin Fong (K)

Department of Science, Technology, Engineering and Public Policy (STEaPP), University College London, London, UK; Department of Anaesthesia, University College London Hospital, London, UK.

Neil Greenberg (N)

King's Centre for Military Health Research, Institute of Psychology, Psychiatry and Neuroscience, London, UK; Health Protection Research Unit, Institute of Psychology, Psychiatry and Neuroscience, King's College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH